Damman, K., Gori, M., Claggett, B., Jhund, P. S., Senni, M., Lefkowitz, M. P., … McMurray, J. J. V. (2018). Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC: Heart Failure, 6(6), 489–498. https://doi.org/10.1016/j.jchf.2018.02.004

Damman, Kevin, Mauro Gori, Brian Claggett, Pardeep S. Jhund, Michele Senni, Martin P. Lefkowitz, Margaret F. Prescott, et al. “Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.” JACC: Heart Failure 6, no. 6 (June 2018): 489–98. https://doi.org/10.1016/j.jchf.2018.02.004.

Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, et al. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC: Heart Failure. 2018 Jun;6(6):489–98.

Damman, Kevin, et al. “Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.” JACC: Heart Failure, vol. 6, no. 6, Elsevier BV, June 2018, pp. 489–98. Crossref, doi:10.1016/j.jchf.2018.02.004.

Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray JJV. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC: Heart Failure. Elsevier BV; 2018 Jun;6(6):489–498.